These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35200436)

  • 1. Systematic Investigation of the Effects of Multiple SV40 Nuclear Localization Signal Fusion on the Genome Editing Activity of Purified SpCas9.
    Shui S; Wang S; Liu J
    Bioengineering (Basel); 2022 Feb; 9(2):. PubMed ID: 35200436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral Capsid-Mediated
    Lu Z; Yao X; Lyu P; Yadav M; Yoo K; Atala A; Lu B
    CRISPR J; 2021 Dec; 4(6):914-928. PubMed ID: 33733873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome Editing in Ferret Airway Epithelia Mediated by CRISPR/Nucleases Delivered with Amphiphilic Shuttle Peptides.
    Luo M; Ma J; Cheng X; Wu S; Bartels DJ; Guay D; Engelhardt JF; Liu X
    Hum Gene Ther; 2023 Aug; 34(15-16):705-718. PubMed ID: 37335046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9.
    Montagna C; Petris G; Casini A; Maule G; Franceschini GM; Zanella I; Conti L; Arnoldi F; Burrone OR; Zentilin L; Zacchigna S; Giacca M; Cereseto A
    Mol Ther Nucleic Acids; 2018 Sep; 12():453-462. PubMed ID: 30195783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
    Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hitchhiking of Cas9 with nucleus-localized proteins impairs its controllability and leads to efficient genome editing of NLS-free Cas9.
    Zhang W; Wang H; Luo Z; Jian Y; Gong C; Wang H; Lin X; Liu M; Wang Y; Shao H
    Mol Ther; 2024 Apr; 32(4):920-934. PubMed ID: 38341611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Improvement of CRISPR-Cas9 System With Ubiquitin-Associated Domain Fusion for Efficient Plant Genome Editing.
    Zheng X; Qi C; Yang L; Quan Q; Liu B; Zhong Z; Tang X; Fan T; Zhou J; Zhang Y
    Front Plant Sci; 2020; 11():621. PubMed ID: 32508867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of Cas9 Ribonucleoproteins for Genome Editing.
    Lin SW; Nguyen VQ; Lin S
    Bio Protoc; 2022 May; 12(10):e4420. PubMed ID: 35813026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of nuclear localization signal-fused Cas9 in the production of genome-edited mice via embryo electroporation.
    Niinuma S; Wake Y; Nakagawa Y; Kaneko T
    Biochem Biophys Res Commun; 2023 Dec; 685():149140. PubMed ID: 37918326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 11. CRISPR based targeted genome editing of Chlamydomonas reinhardtii using programmed Cas9-gRNA ribonucleoprotein.
    Dhokane D; Bhadra B; Dasgupta S
    Mol Biol Rep; 2020 Nov; 47(11):8747-8755. PubMed ID: 33074412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A stable DNA-free screening system for CRISPR/RNPs-mediated gene editing in hot and sweet cultivars of Capsicum annuum.
    Kim H; Choi J; Won KH
    BMC Plant Biol; 2020 Oct; 20(1):449. PubMed ID: 33004008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Robust Expression and Purification Method for Production of
    Fleitas AL; Señorale M; Vidal S
    Methods Protoc; 2022 May; 5(3):. PubMed ID: 35736545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9; A robust technology for producing genetically engineered plants.
    Farooq R; Hussain K; Nazir S; Javed MR; Masood N
    Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):31-38. PubMed ID: 30511631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple in Vivo Gene Editing via Direct Self-Assembly of Cas9 Ribonucleoprotein Complexes for Cancer Treatment.
    Kim SM; Shin SC; Kim EE; Kim SH; Park K; Oh SJ; Jang M
    ACS Nano; 2018 Aug; 12(8):7750-7760. PubMed ID: 30028587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytosolic and Nuclear Delivery of CRISPR/Cas9-ribonucleoprotein for Gene Editing Using Arginine Functionalized Gold Nanoparticles.
    Mout R; Rotello VM
    Bio Protoc; 2017 Oct; 7(20):. PubMed ID: 29226180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
    Li S; Song Z; Liu C; Chen XL; Han H
    ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 replication using the CRISPR/cas9-no NLS system as a prophylactic strategy.
    Salimi-Jeda A; Esghaei M; Hossein Keyvani ; Bokharaei-Salim F; Teimoori A; Abdoli A
    Heliyon; 2022 Sep; 8(9):e10483. PubMed ID: 36158108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.
    Schumann K; Lin S; Boyer E; Simeonov DR; Subramaniam M; Gate RE; Haliburton GE; Ye CJ; Bluestone JA; Doudna JA; Marson A
    Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10437-42. PubMed ID: 26216948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-depth assessment of the PAM compatibility and editing activities of Cas9 variants.
    Zhang W; Yin J; Zhang-Ding Z; Xin C; Liu M; Wang Y; Ai C; Hu J
    Nucleic Acids Res; 2021 Sep; 49(15):8785-8795. PubMed ID: 34133740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.